Document is current
Any future updates will be listed below
-
Authors
Leal Rodríguez, Cristina http://orcid.org/0000-0002-3133-0630
Shah, Shiraz A. http://orcid.org/0000-0002-4665-577X
Rasmussen, Morten Arendt http://orcid.org/0000-0001-7431-5206
Thorsen, Jonathan http://orcid.org/0000-0003-0200-0461
Boulund, Ulrika http://orcid.org/0000-0002-2866-9262
Pedersen, Casper-Emil Tingskov http://orcid.org/0000-0003-2540-5373
Castro-Mejía, Josué L. http://orcid.org/0000-0002-1416-8205
Poulsen, Christina Egeø
Poulsen, Casper Sahl
Deng, Ling http://orcid.org/0000-0002-2190-9788
Larsen, Frej Andreas Nøhr http://orcid.org/0000-0003-2335-3418
Widdowson, Michael http://orcid.org/0000-0001-9715-568X
Zhang, Yichang
Sørensen, Søren J. http://orcid.org/0000-0001-6227-9906
Moineau, Sylvain http://orcid.org/0000-0002-2832-5101
Petit, Marie-Agnès http://orcid.org/0000-0003-2242-2768
Chawes, Bo http://orcid.org/0000-0001-6846-6243
Bønnelykke, Klaus http://orcid.org/0000-0003-2003-1018
Nielsen, Dennis S. http://orcid.org/0000-0001-8121-1114
Stokholm, Jakob http://orcid.org/0000-0003-4989-9769
- License Information
-
More Information
Article History
Received: 14 June 2023
Accepted: 7 November 2023
First Online: 15 December 2023
Competing interests
: J.T. has received speaking fee from AstraZeneca. S.A.S. has been a consultant for Profluent. D.S.N. has been a consultant for Pfizer and Sniprbiome. All other authors have no competing interests. The funding agencies did not have any role in the design and conduct of the study; collection, management, and interpretation of the data; or preparation, review or approval of the manuscript. No pharmaceutical company was involved in the study.
